LP18093-2
Nabumetone
Active
Description
Nabumetone is a non-steroidal anti-inflammatory drug (NSAID), the only 1-naphthaleneacetic acid derivative. Nabumetone has been developed by Beecham. It is available under numerous brand names, such as Relafen, Relifex and Gambaran.
It is used to treat pain or inflammation caused by arthritis. Nabumetone works by reducing the effects of hormones that cause pain and inflammation.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia
, Nabumetone
Basic Part Properties
- Part Name
- Nabumetone
- Part Display Name
- Nabumetone
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2000-05-04
- Construct for LOINC Short Name
- Nabumetone
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP18093-2 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP18093-2
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
zh-CN | Chinese (China) | 萘丁美酮 Synonyms: 4-(6-甲氧基-2-萘基)-2-丁酮 |
es-ES | Spanish (Spain) | Nabumetona |
it-IT | Italian (Italy) | Nabumetone |
et-EE | Estonian (Estonia) | Nabumetoon |
tr-TR | Turkish (Turkey) | Nabumeton |
ru-RU | Russian (Russian Federation) | Набуметон |
fr-BE | French (Belgium) | Nabumétone |
fr-CA | French (Canada) | Nabumétone |
nl-NL | Dutch (Netherlands) | nabumeton |
el-GR | Greek (Greece) | Ναμπουμετόνη Synonyms: Ναμπουμετόνη |
LOINC Copyright
Copyright © 2025 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://